ENDAVA PLC- SPON ADR (DAVA)

US29260V1052 - ADR

27.98  -0.5 (-1.76%)

Fundamental Rating

4

Overall DAVA gets a fundamental rating of 4 out of 10. We evaluated DAVA against 84 industry peers in the IT Services industry. Both the profitability and the financial health of DAVA get a neutral evaluation. Nothing too spectacular is happening here. DAVA is not valued too expensively and it also shows a decent growth rate.



4

1. Profitability

1.1 Basic Checks

DAVA had positive earnings in the past year.
In the past year DAVA had a positive cash flow from operations.
In the past 5 years DAVA has always been profitable.
In the past 5 years DAVA always reported a positive cash flow from operatings.

1.2 Ratios

DAVA's Return On Assets of 1.69% is in line compared to the rest of the industry. DAVA outperforms 52.44% of its industry peers.
Looking at the Return On Equity, with a value of 2.68%, DAVA is in line with its industry, outperforming 56.10% of the companies in the same industry.
With a Return On Invested Capital value of 1.71%, DAVA perfoms like the industry average, outperforming 52.44% of the companies in the same industry.
DAVA had an Average Return On Invested Capital over the past 3 years of 9.56%. This is in line with the industry average of 9.59%.
The 3 year average ROIC (9.56%) for DAVA is well above the current ROIC(1.71%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 1.69%
ROE 2.68%
ROIC 1.71%
ROA(3y)9.09%
ROA(5y)8.43%
ROE(3y)12.79%
ROE(5y)12.33%
ROIC(3y)9.56%
ROIC(5y)9.48%

1.3 Margins

DAVA has a Profit Margin (2.32%) which is comparable to the rest of the industry.
DAVA's Profit Margin has declined in the last couple of years.
DAVA has a Operating Margin (2.72%) which is in line with its industry peers.
DAVA's Operating Margin has declined in the last couple of years.
DAVA has a worse Gross Margin (24.26%) than 70.73% of its industry peers.
In the last couple of years the Gross Margin of DAVA has declined.
Industry RankSector Rank
OM 2.72%
PM (TTM) 2.32%
GM 24.26%
OM growth 3Y-42.43%
OM growth 5Y-25.01%
PM growth 3Y-38.1%
PM growth 5Y-22.63%
GM growth 3Y-12.29%
GM growth 5Y-7.83%

4

2. Health

2.1 Basic Checks

DAVA has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for DAVA has been increased compared to 1 year ago.
Compared to 5 years ago, DAVA has more shares outstanding
The debt/assets ratio for DAVA is higher compared to a year ago.

2.2 Solvency

An Altman-Z score of 3.87 indicates that DAVA is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 3.87, DAVA is doing good in the industry, outperforming 64.63% of the companies in the same industry.
The Debt to FCF ratio of DAVA is 4.15, which is a neutral value as it means it would take DAVA, 4.15 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 4.15, DAVA is in line with its industry, outperforming 59.76% of the companies in the same industry.
A Debt/Equity ratio of 0.29 indicates that DAVA is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.29, DAVA is in line with its industry, outperforming 57.32% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 4.15
Altman-Z 3.87
ROIC/WACC0.21
WACC8.18%

2.3 Liquidity

DAVA has a Current Ratio of 1.74. This is a normal value and indicates that DAVA is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.74, DAVA perfoms like the industry average, outperforming 58.54% of the companies in the same industry.
DAVA has a Quick Ratio of 1.74. This is a normal value and indicates that DAVA is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of DAVA (1.74) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.74
Quick Ratio 1.74

6

3. Growth

3.1 Past

The earnings per share for DAVA have decreased strongly by -52.96% in the last year.
The Earnings Per Share has been growing by 8.26% on average over the past years. This is quite good.
Looking at the last year, DAVA shows a decrease in Revenue. The Revenue has decreased by -6.79% in the last year.
Measured over the past years, DAVA shows a very strong growth in Revenue. The Revenue has been growing by 20.81% on average per year.
EPS 1Y (TTM)-52.96%
EPS 3Y-4.56%
EPS 5Y8.26%
EPS Q2Q%-34.03%
Revenue 1Y (TTM)-6.79%
Revenue growth 3Y18.4%
Revenue growth 5Y20.81%
Sales Q2Q%4.99%

3.2 Future

The Earnings Per Share is expected to grow by 29.31% on average over the next years. This is a very strong growth
Based on estimates for the next years, DAVA will show a quite strong growth in Revenue. The Revenue will grow by 16.24% on average per year.
EPS Next Y2.25%
EPS Next 2Y20.12%
EPS Next 3Y23.39%
EPS Next 5Y29.31%
Revenue Next Year8.2%
Revenue Next 2Y9.27%
Revenue Next 3Y10.82%
Revenue Next 5Y16.24%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 22.21, which indicates a rather expensive current valuation of DAVA.
Based on the Price/Earnings ratio, DAVA is valued a bit cheaper than the industry average as 65.85% of the companies are valued more expensively.
DAVA's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.96.
Based on the Price/Forward Earnings ratio of 13.58, the valuation of DAVA can be described as correct.
DAVA's Price/Forward Earnings ratio is rather cheap when compared to the industry. DAVA is cheaper than 81.71% of the companies in the same industry.
DAVA is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.82, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 22.21
Fwd PE 13.58

4.2 Price Multiples

DAVA's Enterprise Value to EBITDA ratio is in line with the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of DAVA indicates a somewhat cheap valuation: DAVA is cheaper than 62.20% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 26.14
EV/EBITDA 24.45

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates DAVA does not grow enough to justify the current Price/Earnings ratio.
DAVA's earnings are expected to grow with 23.39% in the coming years. This may justify a more expensive valuation.
PEG (NY)9.86
PEG (5Y)2.69
EPS Next 2Y20.12%
EPS Next 3Y23.39%

0

5. Dividend

5.1 Amount

No dividends for DAVA!.
Industry RankSector Rank
Dividend Yield N/A

ENDAVA PLC- SPON ADR

NYSE:DAVA (11/22/2024, 10:45:41 AM)

27.98

-0.5 (-1.76%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.62B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 22.21
Fwd PE 13.58
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)9.86
PEG (5Y)2.69
Profitability
Industry RankSector Rank
ROA 1.69%
ROE 2.68%
ROCE
ROIC
ROICexc
ROICexgc
OM 2.72%
PM (TTM) 2.32%
GM 24.26%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.74
Quick Ratio 1.74
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-52.96%
EPS 3Y-4.56%
EPS 5Y
EPS Q2Q%
EPS Next Y2.25%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-6.79%
Revenue growth 3Y18.4%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y